tiprankstipranks
Kobayashi Pharmaceutical Co Ltd (KBYPF)
OTHER OTC:KBYPF
US Market
KBYPF
Kobayashi Pharmaceutical Co
RESEARCH TOOLSreports

Kobayashi Pharmaceutical Co (KBYPF) Stock Forecast & Price Target

6 Followers
See the Price Targets and Ratings of:

KBYPF Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Kobayashi
Pharmaceutical Co
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

KBYPF Stock 12 Month Forecast

There Are No Analyst Ratings for KBYPF In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

KBYPF Financial Forecast

KBYPF Earnings Forecast

Next quarter’s earnings estimate for KBYPF is $0.41 with a range of $0.41 to $0.41. The previous quarter’s EPS was <$0.01. KBYPF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 38.89% of the time in the same period. In the last calendar year KBYPF has Performed in-line its overall industry.
Next quarter’s earnings estimate for KBYPF is $0.41 with a range of $0.41 to $0.41. The previous quarter’s EPS was <$0.01. KBYPF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 38.89% of the time in the same period. In the last calendar year KBYPF has Performed in-line its overall industry.

KBYPF Sales Forecast

Next quarter’s sales forecast for KBYPF is $286.60M with a range of $277.48M to $292.58M. The previous quarter’s sales results were $233.33M. KBYPF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 57.45% of the time in the same period. In the last calendar year KBYPF has Performed in-line its overall industry.
Next quarter’s sales forecast for KBYPF is $286.60M with a range of $277.48M to $292.58M. The previous quarter’s sales results were $233.33M. KBYPF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 57.45% of the time in the same period. In the last calendar year KBYPF has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on KBYPF
Hisae Kawamoto
Jefferies
Jefferies
$32.7
Hold
-7.70%
Downside
Reiterated
04/17/26
Analysts Offer Insights on Consumer Goods Companies: Coles Group (Other OTC: CLEGF) and Kobayashi Pharmaceutical Co (Other OTC: KBYPF)
Morgan Stanley Analyst forecast on KBYPF
Unknown Analyst
Morgan Stanley
Not Ranked
Morgan Stanley
$33.21
Sell
-6.26%
Downside
Reiterated
01/16/26
Nomura Analyst forecast on KBYPF
Yuji Ohana
Nomura
Nomura
$32.07→$31.76
Hold
-10.36%
Downside
Reiterated
09/10/25
Kobayashi Pharmaceutical Co (KBYPF) Gets a Hold from Nomura
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on KBYPF
Hisae Kawamoto
Jefferies
Jefferies
$32.7
Hold
-7.70%
Downside
Reiterated
04/17/26
Analysts Offer Insights on Consumer Goods Companies: Coles Group (Other OTC: CLEGF) and Kobayashi Pharmaceutical Co (Other OTC: KBYPF)
Morgan Stanley Analyst forecast on KBYPF
Unknown Analyst
Morgan Stanley
Not Ranked
Morgan Stanley
$33.21
Sell
-6.26%
Downside
Reiterated
01/16/26
Nomura Analyst forecast on KBYPF
Yuji Ohana
Nomura
Nomura
$32.07→$31.76
Hold
-10.36%
Downside
Reiterated
09/10/25
Kobayashi Pharmaceutical Co (KBYPF) Gets a Hold from Nomura
Stocks with the Highest Top Analyst Consensus in the Consumer Defensive Sector
MAMAMama's Creations
UTIUniversal Technical Institute
TPBTurning Point Brands
WMTWalmart
PFGCPerformance Food Group
Find stocks in the Consumer Defensive sector that are highly recommended by Top Performing Analysts.

KBYPF Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
1
1
1
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
1
1
1
0
0
In the current month, KBYPF has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. KBYPF average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

KBYPF Stock Forecast FAQ

What is KBYPF’s average 12-month price target, according to analysts?
Currently, no data Available
What is KBYPF’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for KBYPF, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is KBYPF a Buy, Sell or Hold?
      Currently, no data Available
      What is Kobayashi Pharmaceutical Co Ltd’s price target?
      Currently, no data Available
      What do analysts say about Kobayashi Pharmaceutical Co Ltd?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of KBYPF?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.